C.F.R. homeSearch C.F.R.
C.F.R.Title 45Subchapter C—Administrative Data Standards and Related RequirementsPart 164—Security and PrivacySubpart E—Privacy of Individually Identifiable Health Information

45 C.F.R. § 164.502 (2026)

Uses and disclosures of protected health information: General rules

Edition and currency
eCFR text as of Sept. 29, 2026. The text is the edition Syfert holds; for a past event, check the version in force on that date.
Other sources
CURRENTeCFR text as of Sept. 29, 2026 ACTIVE · 100 IN 5Y cited 2004–2026 268citing cases
At a glance

Courts have cited this section in 268 opinions since 2004, 100 of them in the last five years. The most litigated part is subsection (a) (4 cases).

(a) Standard. A covered entity or business associate may not use or disclose protected health information, except as permitted or required by this subpart or by subpart C of part 160 of this subchapter.

(1) Covered entities: Permitted uses and disclosures. A covered entity is permitted to use or disclose protected health information as follows:

(i) To the individual;

(ii) For treatment, payment, or health care operations, as permitted by and in compliance with § 164.506;

(iii) Incident to a use or disclosure otherwise permitted or required by this subpart, provided that the covered entity has complied with the applicable requirements of §§ 164.502(b), 164.514(d), and 164.530(c) with respect to such otherwise permitted or required use or disclosure;

(iv) Except for uses and disclosures prohibited under § 164.502(a)(5)(i), pursuant to and in compliance with a valid authorization under § 164.508;

(v) Pursuant to an agreement under, or as otherwise permitted by, § 164.510; and

(vi) As permitted by and in compliance with any of the following:

(A) This section.

(B) Section 164.512 and, where applicable, § 164.509.

(C) Section 164.514(e), (f), or (g).

(2) Covered entities: Required disclosures. A covered entity is required to disclose protected health information:

(i) To an individual, when requested under, and required by § 164.524 or § 164.528; and

(ii) When required by the Secretary under subpart C of part 160 of this subchapter to investigate or determine the covered entity's compliance with this subchapter.

(3) Business associates: Permitted uses and disclosures. A business associate may use or disclose protected health information only as permitted or required by its business associate contract or other arrangement pursuant to § 164.504(e) or as required by law. The business associate may not use or disclose protected health information in a manner that would violate the requirements of this subpart, if done by the covered entity, except for the purposes specified under § 164.504(e)(2)(i)(A) or (B) if such uses or disclosures are permitted by its contract or other arrangement.

(4) Business associates: Required uses and disclosures. A business associate is required to disclose protected health information:

(i) When required by the Secretary under subpart C of part 160 of this subchapter to investigate or determine the business associate's compliance with this subchapter.

(ii) To the covered entity, individual, or individual's designee, as necessary to satisfy a covered entity's obligations under § 164.524(c)(2)(ii) and (3)(ii) with respect to an individual's request for an electronic copy of protected health information.

(5) Prohibited uses and disclosures—(i) Use and disclosure of genetic information for underwriting purposes: Notwithstanding any other provision of this subpart, a health plan, excluding an issuer of a long-term care policy falling within paragraph (1)(viii) of the definition of health plan, shall not use or disclose protected health information that is genetic information for underwriting purposes. For purposes of paragraph (a)(5)(i) of this section, underwriting purposes means, with respect to a health plan:

(A) Except as provided in paragraph (a)(5)(i)(B) of this section:

(1) Rules for, or determination of, eligibility (including enrollment and continued eligibility) for, or determination of, benefits under the plan, coverage, or policy (including changes in deductibles or other cost-sharing mechanisms in return for activities such as completing a health risk assessment or participating in a wellness program);

(2) The computation of premium or contribution amounts under the plan, coverage, or policy (including discounts, rebates, payments in kind, or other premium differential mechanisms in return for activities such as completing a health risk assessment or participating in a wellness program);

(3) The application of any pre-existing condition exclusion under the plan, coverage, or policy; and

(4) Other activities related to the creation, renewal, or replacement of a contract of health insurance or health benefits.

(B) Underwriting purposes does not include determinations of medical appropriateness where an individual seeks a benefit under the plan, coverage, or policy.

(ii) Sale of protected health information:

(A) Except pursuant to and in compliance with § 164.508(a)(4), a covered entity or business associate may not sell protected health information.

(B) For purposes of this paragraph, sale of protected health information means:

(1) Except as provided in paragraph (a)(5)(ii)(B)(2) of this section, a disclosure of protected health information by a covered entity or business associate, if applicable, where the covered entity or business associate directly or indirectly receives remuneration from or on behalf of the recipient of the protected health information in exchange for the protected health information.

(2) Sale of protected health information does not include a disclosure of protected health information:

(i) For public health purposes pursuant to § 164.512(b) or § 164.514(e);

(ii) For research purposes pursuant to § 164.512(i) or § 164.514(e), where the only remuneration received by the covered entity or business associate is a reasonable cost-based fee to cover the cost to prepare and transmit the protected health information for such purposes;

(iii) For treatment and payment purposes pursuant to § 164.506(a);

(iv) For the sale, transfer, merger, or consolidation of all or part of the covered entity and for related due diligence as described in paragraph (6)(iv) of the definition of health care operations and pursuant to § 164.506(a);

(v) To or by a business associate for activities that the business associate undertakes on behalf of a covered entity, or on behalf of a business associate in the case of a subcontractor, pursuant to §§ 164.502(e) and 164.504(e), and the only remuneration provided is by the covered entity to the business associate, or by the business associate to the subcontractor, if applicable, for the performance of such activities;

(vi) To an individual, when requested under § 164.524 or § 164.528;

(vii) Required by law as permitted under § 164.512(a); and

(viii) For any other purpose permitted by and in accordance with the applicable requirements of this subpart, where the only remuneration received by the covered entity or business associate is a reasonable, cost-based fee to cover the cost to prepare and transmit the protected health information for such purpose or a fee otherwise expressly permitted by other law.

(iii) Reproductive health care—(A) Prohibition. Subject to paragraphs (a)(5)(iii)(B) and (C) of this section, a covered entity or business associate may not use or disclose protected health information for any of the following activities:

(1) To conduct a criminal, civil, or administrative investigation into any person for the mere act of seeking, obtaining, providing, or facilitating reproductive health care.

(2) To impose criminal, civil, or administrative liability on any person for the mere act of seeking, obtaining, providing, or facilitating reproductive health care.

(3) To identify any person for any purpose described in paragraphs (a)(5)(iii)(A)(1) or (2) of this section.

(B) Rule of applicability. The prohibition at paragraph (a)(5)(iii)(A) of this section applies only where the relevant activity is in connection with any person seeking, obtaining, providing, or facilitating reproductive health care, and the covered entity or business associate that received the request for protected health information has reasonably determined that one or more of the following conditions exists:

(1) The reproductive health care is lawful under the law of the state in which such health care is provided under the circumstances in which it is provided.

(2) The reproductive health care is protected, required, or authorized by Federal law, including the United States Constitution, under the circumstances in which such health care is provided, regardless of the state in which it is provided.

(3) The presumption at paragraph (a)(5)(iii)(C) of this section applies.

(C) Presumption. The reproductive health care provided by another person is presumed lawful under paragraph (a)(5)(iii)(B)(1) or (2) of this section unless the covered entity or business associate has any of the following:

(1) Actual knowledge that the reproductive health care was not lawful under the circumstances in which it was provided.

(2) Factual information supplied by the person requesting the use or disclosure of protected health information that demonstrates a substantial factual basis that the reproductive health care was not lawful under the specific circumstances in which it was provided.

(D) Scope. For the purposes of this subpart, seeking, obtaining, providing, or facilitating reproductive health care includes, but is not limited to, any of the following: expressing interest in, using, performing, furnishing, paying for, disseminating information about, arranging, insuring, administering, authorizing, providing coverage for, approving, counseling about, assisting, or otherwise taking action to engage in reproductive health care; or attempting any of the same.

(b) Standard: Minimum necessary— Minimum necessary applies. When using or disclosing protected health information or when requesting protected health information from another covered entity or business associate, a covered entity or business associate must make reasonable efforts to limit protected health information to the minimum necessary to accomplish the intended purpose of the use, disclosure, or request.

(2) Minimum necessary does not apply. This requirement does not apply to:

(i) Disclosures to or requests by a health care provider for treatment;

(ii) Uses or disclosures made to the individual, as permitted under paragraph (a)(1)(i) of this section or as required by paragraph (a)(2)(i) of this section;

(iii) Uses or disclosures made pursuant to an authorization under § 164.508;

(iv) Disclosures made to the Secretary in accordance with subpart C of part 160 of this subchapter;

(v) Uses or disclosures that are required by law, as described by § 164.512(a); and

(vi) Uses or disclosures that are required for compliance with applicable requirements of this subchapter.

(c) Standard: Uses and disclosures of protected health information subject to an agreed upon restriction. A covered entity that has agreed to a restriction pursuant to § 164.522(a)(1) may not use or disclose the protected health information covered by the restriction in violation of such restriction, except as otherwise provided in § 164.522(a).

(d) Standard: Uses and disclosures of de-identified protected health information—(1) Uses and disclosures to create de-identified information. A covered entity may use protected health information to create information that is not individually identifiable health information or disclose protected health information only to a business associate for such purpose, whether or not the de-identified information is to be used by the covered entity.

(2) Uses and disclosures of de-identified information. Health information that meets the standard and implementation specifications for de-identification under § 164.514(a) and (b) is considered not to be individually identifiable health information, i.e., de-identified. The requirements of this subpart do not apply to information that has been de-identified in accordance with the applicable requirements of § 164.514, provided that:

(i) Disclosure of a code or other means of record identification designed to enable coded or otherwise de-identified information to be re-identified constitutes disclosure of protected health information; and

(ii) If de-identified information is re-identified, a covered entity may use or disclose such re-identified information only as permitted or required by this subpart.

(e)(1) Standard: Disclosures to business associates. (i) A covered entity may disclose protected health information to a business associate and may allow a business associate to create, receive, maintain, or transmit protected health information on its behalf, if the covered entity obtains satisfactory assurance that the business associate will appropriately safeguard the information. A covered entity is not required to obtain such satisfactory assurances from a business associate that is a subcontractor.

(ii) A business associate may disclose protected health information to a business associate that is a subcontractor and may allow the subcontractor to create, receive, maintain, or transmit protected health information on its behalf, if the business associate obtains satisfactory assurances, in accordance with § 164.504(e)(1)(i), that the subcontractor will appropriately safeguard the information.

(2) Implementation specification: Documentation. The satisfactory assurances required by paragraph (e)(1) of this section must be documented through a written contract or other written agreement or arrangement with the business associate that meets the applicable requirements of § 164.504(e).

(f) Standard: Deceased individuals. A covered entity must comply with the requirements of this subpart with respect to the protected health information of a deceased individual for a period of 50 years following the death of the individual.

(g)(1) Standard: Personal representatives. As specified in this paragraph, a covered entity must, except as provided in paragraphs (g)(3) and (g)(5) of this section, treat a personal representative as the individual for purposes of this subchapter.

(2) Implementation specification: Adults and emancipated minors. If under applicable law a person has authority to act on behalf of an individual who is an adult or an emancipated minor in making decisions related to health care, a covered entity must treat such person as a personal representative under this subchapter, with respect to protected health information relevant to such personal representation.

(3)(i) Implementation specification: Unemancipated minors. If under applicable law a parent, guardian, or other person acting in loco parentis has authority to act on behalf of an individual who is an unemancipated minor in making decisions related to health care, a covered entity must treat such person as a personal representative under this subchapter, with respect to protected health information relevant to such personal representation, except that such person may not be a personal representative of an unemancipated minor, and the minor has the authority to act as an individual, with respect to protected health information pertaining to a health care service, if:

(A) The minor consents to such health care service; no other consent to such health care service is required by law, regardless of whether the consent of another person has also been obtained; and the minor has not requested that such person be treated as the personal representative;

(B) The minor may lawfully obtain such health care service without the consent of a parent, guardian, or other person acting in loco parentis, and the minor, a court, or another person authorized by law consents to such health care service; or

(C) A parent, guardian, or other person acting in loco parentis assents to an agreement of confidentiality between a covered health care provider and the minor with respect to such health care service.

(ii) Notwithstanding the provisions of paragraph (g)(3)(i) of this section:

(A) If, and to the extent, permitted or required by an applicable provision of State or other law, including applicable case law, a covered entity may disclose, or provide access in accordance with § 164.524 to, protected health information about an unemancipated minor to a parent, guardian, or other person acting in loco parentis;

(B) If, and to the extent, prohibited by an applicable provision of State or other law, including applicable case law, a covered entity may not disclose, or provide access in accordance with § 164.524 to, protected health information about an unemancipated minor to a parent, guardian, or other person acting in loco parentis; and

(C) Where the parent, guardian, or other person acting in loco parentis, is not the personal representative under paragraphs (g)(3)(i)(A), (B), or (C) of this section and where there is no applicable access provision under State or other law, including case law, a covered entity may provide or deny access under § 164.524 to a parent, guardian, or other person acting in loco parentis, if such action is consistent with State or other applicable law, provided that such decision must be made by a licensed health care professional, in the exercise of professional judgment.

(4) Implementation specification: Deceased individuals. If under applicable law an executor, administrator, or other person has authority to act on behalf of a deceased individual or of the individual's estate, a covered entity must treat such person as a personal representative under this subchapter, with respect to protected health information relevant to such personal representation.

(5) Implementation specification: Abuse, neglect, endangerment situations. Notwithstanding a State law or any requirement of this paragraph to the contrary, a covered entity may elect not to treat a person as the personal representative, provided that the conditions at paragraphs (g)(5)(i) and (ii) of this section are met:

(i) Paragraphs (g)(5)(i)(A) and (B) of this section both apply.

(A) The covered entity has a reasonable belief that any of the following is true:

(1) The individual has been or may be subjected to domestic violence, abuse, or neglect by such person.

(2) Treating such person as the personal representative could endanger the individual.

(B) The covered entity, in the exercise of professional judgment, decides that it is not in the best interest of the individual to treat the person as the individual's personal representative.

(ii) The covered entity does not have a reasonable belief under paragraph (g)(5)(i)(A) of this section if the basis for their belief is the provision or facilitation of reproductive health care by such person for and at the request of the individual.

(h) Standard: Confidential communications. A covered health care provider or health plan must comply with the applicable requirements of § 164.522(b) in communicating protected health information.

(i) Standard: Uses and disclosures consistent with notice. A covered entity that is required by § 164.520 to have a notice may not use or disclose protected health information in a manner inconsistent with such notice. A covered entity that is required by § 164.520(b)(1)(iii) to include a specific statement in its notice if it intends to engage in an activity listed in § 164.520(b)(1)(iii)(A)-(C), may not use or disclose protected health information for such activities, unless the required statement is included in the notice.

(j) Standard: Disclosures by whistleblowers and workforce member crime victims—(1) Disclosures by whistleblowers. A covered entity is not considered to have violated the requirements of this subpart if a member of its workforce or a business associate discloses protected health information, provided that:

(i) The workforce member or business associate believes in good faith that the covered entity has engaged in conduct that is unlawful or otherwise violates professional or clinical standards, or that the care, services, or conditions provided by the covered entity potentially endangers one or more patients, workers, or the public; and

(ii) The disclosure is to:

(A) A health oversight agency or public health authority authorized by law to investigate or otherwise oversee the relevant conduct or conditions of the covered entity or to an appropriate health care accreditation organization for the purpose of reporting the allegation of failure to meet professional standards or misconduct by the covered entity; or

(B) An attorney retained by or on behalf of the workforce member or business associate for the purpose of determining the legal options of the workforce member or business associate with regard to the conduct described in paragraph (j)(1)(i) of this section.

(2) Disclosures by workforce members who are victims of a crime. A covered entity is not considered to have violated the requirements of this subpart if a member of its workforce who is the victim of a criminal act discloses protected health information to a law enforcement official, provided that:

(i) The protected health information disclosed is about the suspected perpetrator of the criminal act; and

(ii) The protected health information disclosed is limited to the information listed in § 164.512(f)(2)(i).

[65 FR 82802, Dec. 28, 2000, as amended at 67 FR 53267, Aug. 14, 2002; 78 FR 5696, Jan. 25, 2013; 89 FR 33063, Apr. 26, 2024]
The 20 cases that cite 45 C.F.R. § 164.502 most heavily, weighted by court and treatment. RelevanceNewestTreatment
1
GREENAlvista Healthcare Ctr., Inc. v. Miller, 686 S.E.2d 96 (Ga. 2009).
cites § 164.502 50×cited by 4 cases
Where it cites § 164.502
“Miller "has authority to act on behalf of a deceased individual or of the individual's estate" and, therefore, must be treated as a "personal representative" to whom protected health information may be disclosed.”
Later courts cite it for
“person who is required to act for the benefit of another person on all matters within the scope of their relationship; one who owes to another the duties of good faith, trust, confidence, and candor.” · 2 citing courts
2
GREENArons v. Jutkowitz, 880 N.E.2d 831 (N.Y. 2007).
cites § 164.502 8×cited by 105 cases
Where it cites § 164.502
“The Privacy Rule mandates disclosure in only two situations: when an individual asks a covered entity for his or her own health information, or when the Secretary of HHS asks a covered entity for access to such information in order to enforce HIPAA (45 CFR 164.502 [a] [2]). [3]…”
The case’s holding
Attorneys may conduct ex parte interviews with nonparty treating physicians because state law allows informal discovery and does not conflict with HIPAA requirements.
Later courts cite it for
“as a practical matter, this means that the attorney who wishes to contact an adverse party's treating physician must first obtain a valid hipaa authorization or a court of administrative order; or must issue a subpoena, discovery request or other lawful process with satisfactory assurances relating to either notification or a qualified protective order.” · 3 citing courts
3
GREENCohan v. Ayabe., 322 P.3d 948 (Haw. 2014).
cites § 164.502 18×cited by 13 cases
Where it cites § 164.502
“45 C.F.R. § 164.502 (a)(1)(iii). There are several other regulations related to a covered entity’s uses and disclosures of protected health information, such as requests for health information ( 45 C.”
The case’s holding
Hawaii's constitutional privacy provision bars disclosure outside the underlying litigation of a party's health information obtained in discovery, regardless of de-identification, absent a showing of a compelling state interest.
Later courts cite it for
“social and psychological harm through embarrassment, economic harm through job discrimination and job loss, patient difficulty in obtaining health insurance, health care fraud, and patient reluctance to share sensitive information with their doctors or pharmacists.” · 2 citing courts
4
GREENNw. Mem'l Hosp. v. John Ashcroft, 362 F.3d 923 (7th Cir. 2004).
cites § 164.502 5×cited by 163 cases
Where it cites § 164.502
“” 45 C.F.R. § 164.502 (a). Before looking to the various exceptions, the initial question is whether the information sought in this case is “protected health information.”
The case’s holding
Federal Rule of Civil Procedure 26(b)(1) governs the scope of discovery for subpoenas seeking hospital records (applying Rule 26(b)(1) to a subpoena for hospital records).
Later courts cite it for
“pretrial discovery is a fishing expedition and one can't know what one has caught until one fishes.” · 7 citing courts
5
GREENHolman v. RASAK, 785 N.W.2d 98 (Mich. 2010).
cites § 164.502 7×subsections: (a) 7×cited by 41 cases
Where it cites § 164.502
“Pursuant to that legislative mandate, 45 CFR 164.502(a) provides that "[a] covered entity may not use or disclose protected health information, except as permitted or required by this subpart.”
The case’s holding
HIPAA does not preempt state law permitting ex parte interviews with treating physicians if reasonable efforts are made to secure a qualified protective order.
Later courts cite it for
“a trial court retains its discretion under mcr 2.302(c) to issue protective orders and to impose conditions on ex parte interviews.” · 4 citing courts
cites § 164.502 5×cited by 89 cases
Where it cites § 164.502
“45 C.F.R. § 164.502 (2003). The definition of a covered entity is a health plan, a health care clearinghouse, or a health care provider "who transmits any health information in electronic form in connection with a transaction covered by this subchapter.”
The case’s holding
Unauthorized disclosure of medical information does not constitute a transfer of resident property because the information is not severed from the resident or the facility.
Later courts cite it for
“issue presented is purely a matter of law, we employ a de novo standard.” · 1 citing court
7
GREENIn re the Est. of Broderick, 125 P.3d 564 (Kan. Ct. App. 2005).
cites § 164.502 7×cited by 20 cases
Where it cites § 164.502
“” 45 C.F.R. § 164.502 (f) (2004). In cases of a deceased individual, the covered entity must “treat a personal representative as the individual.”
Later courts cite it for
“while pro se pleadings are to be liberally construed so that relief may be granted if warranted by the facts alleged, this simply means that the substance of the pleading controls over its label.” · 3 citing courts
8
GREENOpis Mgmt. Resources, LLC v. Sec'y, 713 F.3d 1291 (11th Cir. 2013).
cites § 164.502 6×cited by 14 cases
Where it cites § 164.502
“1 See 45 C.F.R. § 164.502 . 2 Consequently, the requesting parties filed complaints with the U.”
Later courts cite it for
“one of congress's objectives in enacting hipaa was to address concerns about the confidentiality of patients' individually identifiable health information.” · 2 citing courts
cites § 164.502 2×cited by 118 cases
Where it cites § 164.502
“In determining whether medical records are relevant for purposes of litigation, defendants should continue to adhere to the “minimum necessary” standard that traditionally applies to a provider’s use and disclosure of a patient’s private health records under 45 C.F.R. § 164.502…”
The case’s holding
Substantial compliance with statutory HIPAA authorization requirements is permissible if the errors do not frustrate the statute's purpose or prejudice the opposing party.
Later courts cite it for
“in determining whether a plaintiff has substantially complied with a statutory requirement, a reviewing court should consider the extent and significance of the plaintiff's errors and omissions and whether the defendant was prejudiced by the plaintiff's noncompliance.” · 20 citing courts
10
GREENACA Int'l v. Fed. Commc'ns Comm'n, 885 F.3d 687 (D.C. Cir. 2018).
cites § 164.502 1×cited by 176 cases
Where it cites § 164.502
“" 45 C.F.R. § 164.502 (a). But they are generally permitted to use or disclose that information "for treatment, payment, or health care operations.”
The case’s holding
The Commission may interpret the autodialer ban to apply either to devices with random number generation capabilities or to those without such capabilities.
Later courts cite it for
“but the commission cannot, consistent with reasoned decisionmaking, espouse both competing interpretations in the same order.” · 11 citing courts
11
GREEND.L. v. Sheppard Pratt Health Sys., 214 A.3d 521 (Md. 2019).
cites § 164.502 2×cited by 31 cases
Where it cites § 164.502
“§ 1320d(6); 45 CFR § 164.502 (a). The associated HIPAA provisions also significantly limit external access to protected health information.”
The case’s holding
An involuntary psychiatric admission carrying possible collateral consequences, such as the stigma attached to mental illness, is not rendered moot by the patient's release, so judicial review may proceed.
Later courts cite it for
“generally, a case is moot if no controversy exists between the parties.” · 7 citing courts
12
GREENHaage v. Zavala, 2021 IL 125918, 183 N.E.3d 830.
cites § 164.502 2×cited by 30 cases
Where it cites § 164.502
“45 C.F.R. § 164.502 (a) (2018). PHI is defined as “individually identifiable health information” that is kept or transmitted in electronic or any other form of media.”
The case’s holding
A trial court does not abuse its discretion in entering HIPAA qualified protective orders barring nonlitigation use of PHI and requiring its return or destruction, and noncovered insurers must comply.
Later courts cite it for
“an abuse of discretion occurs only when the trial court's decision is arbitrary, fanciful, or unreasonable or where no reasonable person would take the view adopted by the trial court.” · 7 citing courts
13
GREENFranklin Collection Serv., Inc. v. Kyle, 955 So. 2d 284 (Miss. 2007).
cites § 164.502 3×cited by 29 cases
Where it cites § 164.502
“45 C.F.R. § 164.502 (e)(1). Disclosure is restricted to the "minimum necessary" to collect the debt, and the collection agency must be on notice that it too is expected to protect the private information.”
Later courts cite it for
“parties may not simply rely on their pleadings, nor may they escape summary judgment by outlining what they might discover later.” · 2 citing courts
14
GREENVaughn v. Epworth Villa, 537 F.3d 1147 (10th Cir. 2008).
cites § 164.502 2×cited by 65 cases
Where it cites § 164.502
“” 45 C.F.R. § 164.502 (a). "Protected health information” includes "individually identifiable health information” that is "[tjransmitted or maintained in any .”
The case’s holding
Submitting unredacted medical records to the EEOC constitutes protected activity, but violating confidentiality policies provides a legitimate, non-retaliatory reason for termination if not pretextual.
Later courts cite it for
“(1) she engaged in protected activity; (2) she suffered an adverse employment action; and (3) there was a causal connection between the protected activity and the adverse action.” · 8 citing courts
15
GREENPremier, Inc. v. Peterson, 804 S.E.2d 599 (N.C. Ct. App. 2017).
cites § 164.502 4×cited by 6 cases
Where it cites § 164.502
“See generally 45 C.F.R. §§ 164.502 , 164.508. In such a scenario, the parent Hospital Network signs the BAA on behalf of the individual Hospital Sites.”
Later courts cite it for
“we limit our discussion in this opinion to the facts and procedural history relevant to the issues currently before us.” · 4 citing courts
16
GREENState ex rel. Proctor v. Messina, 320 S.W.3d 145 (Mo. 2010).
cites § 164.502 3×cited by 21 cases
Later courts cite it for
“a federal law will preempt state law only when it is the clear and manifest purpose of congress to do so.” · 2 citing courts
17
GREENCaldwell v. Chauvin, 464 S.W.3d 139 (Ky. 2015).
cites § 164.502 2×cited by 48 cases
The case’s holding
Kentucky law and HIPAA do not prohibit ex parte interviews with nonexpert treating physicians, though HIPAA requires a court order to authorize the disclosure of protected health information.
Later courts cite it for
“requirements are met and error found, the grant of a writ remains within the sole discretion of the court.” · 6 citing courts
18
GREENTexas West Oaks Hosp., LP v. Williams, 371 S.W.3d 171 (Tex. 2012).
cites § 164.502 1×cited by 297 cases
Where it cites § 164.502
“45 C.F.R. § 164.502 (f) (providing that Health Insurance Privacy and Portability Act restrictions apply to deceased individuals).”
The case’s holding
A claim is a health care liability claim if expert medical or health care testimony is necessary to prove or refute the merits of the claim.
Later courts cite it for
“if expert medical or health care testimony is necessary to prove or refute the merits of the claim against a physician or health care provider, the claim is a health care liability claim.” · 17 citing courts
19
GREENHarrold-Jones v. Drury, 422 P.3d 568 (Alaska 2018).
cites § 164.502 3×cited by 8 cases
Where it cites § 164.502
“15 See 45 C.F.R. § 164.502 (a) ("A covered entity or business associate may not use or disclose protected health information, except as permitted or required by [HIPAA].”
Later courts cite it for
“cultural shift emphasizing medical privacy” · 1 citing court
20
GREENMenorah Park Ctr. for Senior Living v. Rolston, 2020-Ohio-6658, 173 N.E.3d 432.
cites § 164.502 2×subsections: (a)(1)(ii) (b)(1)cited by 15 cases
Where it cites § 164.502
“) 45 C.F.R. 164.502(a)(1)(ii). Payment means “activities undertaken by” a healthcare provider “to obtain or provide reimbursement for the provision of health care.”
Later courts cite it for
“it is well-settled that a hipaa violation does not create a private cause of action for the party whose information has been released.” · 3 citing courts

Show all 268 citing cases (list view) →

The flag is Syfertize’s treatment of the citing case itself, not of the statute. “Where it cites” is the passage in the opinion; the holding is a summary of the whole case and may concern another point. Annotations are extracted automatically from the opinions in the Syfert caselaw corpus.

Citing cases by year
200420152026

One bar per year. Tallest: 30 cases in 2025. 2026 is a partial year. These are opinions in the Syfert collection, which holds more of some courts’ recent opinions than their older ones, so a rise can reflect what the collection holds and not more litigation.

By court
Tex. App.25S.D.N.Y.10Ohio Ct. App.9Ill. App. Ct.8Cal. Ct. App.6D. Ariz.511th Cir.5D.D.C.5

The 8 courts with the most citing cases, of 119 courts in all.

By subsection
(a)4 cases
Holman v. RASAK, 785 N.W.2d 98 (Mich. 2010).“Pursuant to that legislative mandate, 45 CFR 164.502(a) provides that "[a] covered entity may not use or disclose protected health information, except as permitted or required by this subpart.”
In re Petition of Atty. Gen. for Investigative Subpoenas, 736 N.W.2d 594 (Mich. Ct. App. 2007).
Oregon Health & Sci. Univ. v. Oregonian Publ'g Co., 373 P.3d 1233 (Multnomah Cty. Cir. Ct., O.R. 2016).
Henckel v. Belanger, No. CUMcv-07-435 (Me. Super. Ct May 9, 2008).
(a)(1)2 cases
Deer Run Estates, LLC v. Hon Darren W. Peckler Judge, No. 2014 SC 000390 (Ky. June 8, 2015).
Deer Run Estates, LLC v. Hon Darren W. Peckler Judge, No. 2014 SC 000390 (Ky. July 9, 2015).
(a)(1)(ii)2 cases
Menorah Park Ctr. for Senior Living v. Rolston, 2020-Ohio-6658, 173 N.E.3d 432.“) 45 C.F.R. 164.502(a)(1)(ii). Payment means “activities undertaken by” a healthcare provider “to obtain or provide reimbursement for the provision of health care.”
(b)2 cases
Dept. of Human Servs. v. M. A. H., No. A181606 (Or. Ct. App. Apr. 17, 2024).
(b)(1)1 case
Menorah Park Ctr. for Senior Living v. Rolston, 2020-Ohio-6658, 173 N.E.3d 432.
(d)1 case
(d)(1)1 case
(f)3 cases
Jennifer Lynn Alsip v. Johnson City Med. Ctr., No. E2004-00831-COA-R9-CV, 2005 WL 1536192 (Tenn. Ct. App. June 30, 2005).
(g)1 case
Theron Ingram v. Brook Chateau, 586 S.W.3d 772 (Mo. 2019).
(g)(3)(i)1 case
Wade Loyning v. Neisha Potter, 2024 WY 82, 553 P.3d 128.
(j)(1)1 case
Newell, No. 1:24-cv-01224 (W.D. Tenn. Nov. 17, 2025).

Show all 268 citing cases (list view) →

Enactment and amendments

Syfert holds no separate history line for this section. Where this code prints a source or history note, it appears with the text, usually at the end.

Versions

Edition shown: eCFR text as of Sept. 29, 2026. Syfert holds no earlier or later version of this section.

C.F.R. Home  |  Search C.F.R.  |  Search cases for this section  |  syfert.com